SCHEMBL21032833

SCHEMBL21032833

c1ccc(-c2ccc3c(c2)c2ccccc2n3-c2ccc(-c3cccc(-n4c5ccccc5c5ccccc54)c3)cc2-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
ATM Q13315 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PDE10A Q9Y233 1/20 0.35
PTGER4 P35408 1/20 0.35
TSPO P30536 1/20 0.34
NPY5R Q15761 1/20 0.33
ABCG2 Q9UNQ0 3/20 0.32
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
GRM5 P41594 1/20 0.32
GAA P10253 1/20 0.32
POLB P06746 1/20 0.32
CTDSP1 Q9GZU7 1/20 0.32
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
RAC2 P15153 1/20 0.31
RAC3 P60763 1/20 0.31
CDC42 P60953 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21032831 1.00 KDM4E (0.39) KDM4EATML3MBTL1PDE10APTGER4
SCHEMBL22585938 0.95 KDM4E (0.44) KDM4EATML3MBTL1PTGER4TSPO
SCHEMBL22585937 0.95 KDM4E (0.44) KDM4EATML3MBTL1PTGER4TSPO
SCHEMBL21031695 0.95 KDM4E (0.42) KDM4EATML3MBTL1PDE10AABCG2
SCHEMBL23510211 0.94 L3MBTL1 (0.41) KDM4EATML3MBTL1PDE10APTGER4
SCHEMBL21147369 0.94 ATM (0.38) KDM4EATML3MBTL1PDE10APTGER4
SCHEMBL21147329 0.94 ATM (0.38) KDM4EATML3MBTL1PDE10APTGER4
SCHEMBL21147041 0.94 ATM (0.38) KDM4EATML3MBTL1PDE10APTGER4
SCHEMBL21147879 0.94 ATM (0.38) KDM4EATML3MBTL1PDE10APTGER4
SCHEMBL21147030 0.94 ATM (0.38) KDM4EATML3MBTL1PDE10APTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200358002-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-11-12 US disclosed
WO-2019101594-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200358002-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, AOX1, IKZF3 KDM4E 1845/4885ATM 4067/4885L3MBTL1 3356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.